EXPE · Insider Trading

Expedia Group, Inc. Common Stock

Every open-market purchase and sale reported by EXPE officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
50
most recent
Open-Market Buys
0
code P
Sales
6
code S
Reporting Insiders
16
current holders
EXPE — Recent Form 4 Transactions (latest 2026-10-16)
FiledInsiderRole TypeSharesValue
2026-10-16 Robert J Dzielak Chief Legal Officer & Sec'y MIXED +1,384 −$252.71K
2026-10-05 Dara Khosrowshahi Director A +46 deriv. —
2026-10-05 Alexander Von Furstenberg Director A +2 deriv. —
2026-10-05 Chelsea Clinton Director A +48 deriv. —
2026-10-05 Patricia Menendez-Cambo Director A +65 deriv. —
2026-10-05 Henrique Vasoncelos Dubugras Director A +42 deriv. —
2026-08-25 Robert J Dzielak Chief Legal Officer & Sec'y Sell −1,004 −$336.34K
2026-08-20 Lance A Soliday SVP & Chief Accounting Officer Sell −2,810 −$909.46K
2026-08-18 Lance A Soliday SVP & Chief Accounting Officer MIXED +733 −$160.02K
2026-08-18 Dara Khosrowshahi Director G −15,000 —
2026-08-18 Ariane Gorin Chief Executive Officer MIXED +9,895 −$2.22M
2026-08-18 Derek Andersen Chief Financial Officer MIXED +3,599 −$1.21M
2026-08-18 Robert J Dzielak Chief Legal Officer & Sec'y MIXED +1,506 −$1.44M
2026-08-18 Barry Diller Chairman & Sr. Executive MIXED +3,656 −$1.51M
2026-08-17 Craig A Jacobson Director Sell −3,133 −$1.03M
2026-08-13 Robert J Dzielak Chief Legal Officer & Sec'y Sell −3,003 −$945.95K
2026-07-16 Robert J Dzielak Chief Legal Officer & Sec'y MIXED +1,384 −$244.98K
2026-07-01 Patricia Menendez-Cambo Director A +37 deriv. —
2026-07-01 Henrique Vasoncelos Dubugras Director A +5 deriv. —
2026-07-01 Dara Khosrowshahi Director A +18 deriv. —
2026-07-01 Alexander Von Furstenberg Director A +3 deriv. —
2026-07-01 Chelsea Clinton Director A +34 deriv. —
2026-06-08 Robert J Dzielak Chief Legal Officer & Sec'y Sell −4,702 −$1.10M
2026-06-02 Beverly J Anderson Director M +2,108 —
2026-06-02 Madhumita Moina Banerjee Director M +2,108 —
2026-06-02 Chelsea Clinton Director M +2,108 —
2026-06-02 Henrique Vasoncelos Dubugras Director M +2,108 —
2026-06-02 Craig A Jacobson Director M +2,108 —
2026-06-02 Dara Khosrowshahi Director M +2,108 —
2026-06-02 Patricia Menendez-Cambo Director M +2,108 —
2026-06-02 Alexander Von Furstenberg Director M +2,108 —
2026-06-02 Alexandr Wang Director M +2,108 —
2026-05-28 Lance A Soliday SVP & Chief Accounting Officer Sell −940 −$208.55K
2026-05-19 Ariane Gorin Chief Executive Officer MIXED +9,889 −$1.45M
2026-05-19 Derek Andersen Chief Financial Officer MIXED +4,979 −$487.33K
2026-05-19 Lance A Soliday SVP & Chief Accounting Officer MIXED +741 −$102.94K
2026-05-19 Barry Diller Chairman & Sr. Executive MIXED +3,656 −$983.56K
2026-05-19 Robert J Dzielak Chief Legal Officer & Sec'y MIXED +3,505 −$506.44K
2026-05-13 Derek Andersen Chief Financial Officer A +70,167 deriv. —
2026-04-15 Robert J Dzielak Chief Legal Officer & Sec'y MIXED +1,384 −$228.68K
2026-04-02 Chelsea Clinton Director A +55 deriv. —
2026-04-02 Henrique Vasoncelos Dubugras Director A +48 deriv. —
2026-04-02 Dara Khosrowshahi Director A +52 deriv. —
2026-04-02 Patricia Menendez-Cambo Director A +74 deriv. —
2026-04-02 Alexander Von Furstenberg Director A +3 deriv. —
2026-03-16 Robert J Dzielak Chief Legal Officer & Sec'y MIXED +2,781 −$422.48K
2026-03-16 Scott F. Schenkel Chief Financial Officer MIXED +4,580 −$695.62K
2026-03-11 Barry Diller Chairman & Sr. Executive A +25,372 deriv. —
2026-03-11 Robert J Dzielak Chief Legal Officer & Sec'y A +29,564 deriv. —
2026-03-11 Ariane Gorin Chief Executive Officer A +88,813 deriv. —
EXPE — Current Insider Holders
InsiderRole Shares HeldValue
Barry Diller Chairman & Sr. Executive 163,937 $46.83M
Ariane Gorin Chief Executive Officer 156,223 $44.62M
Dara Khosrowshahi Director 142,276 $40.64M
Robert J Dzielak Chief Legal Officer & Sec'y 105,715 $30.20M
Scott F. Schenkel Chief Financial Officer 32,389 $9.25M
Craig A Jacobson Director 29,832 $8.52M
Alexander Von Furstenberg Director 22,688 $6.48M
Julie Whalen Chief Financial Officer 19,816 $5.66M
Chelsea Clinton Director 18,484 $5.28M
Lance A Soliday SVP & Chief Accounting Officer 12,006 $3.43M
Beverly J Anderson Director 9,355 $2.67M
Patricia Menendez-Cambo Director 8,916 $2.55M
Derek Andersen Chief Financial Officer 8,578 $2.45M
Henrique Vasoncelos Dubugras Director 7,170 $2.05M
Madhumita Moina Banerjee Director 4,505 $1.29M
Alexandr Wang Director 4,088 $1.17M
EXPE Insider Trading FAQ
Who are the insiders at EXPE?
16 officers, directors and 10%+ beneficial owners currently report holdings in EXPE via SEC Form 4.
Are EXPE insiders buying or selling?
Across the 50 most recent Form 4 filings for EXPE, 0 were open-market purchases (code P) and 6 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is EXPE insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent EXPE filing is dated 2026-10-16.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the EXPE quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.